Načítá se...

Targeting CARM1 in ovarian cancer with EZH2 and PARP inhibitors

Coactivator-associated arginine methyltransferase 1 (CARM1)-expressing high-grade serous ovarian cancers are characterized by poor prognosis and limited therapeutic options. Here we discuss a novel therapeutic strategy to target CARM1-expressing ovarian cancer based on a combination of poly (ADP-rib...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Cell Oncol
Hlavní autoři: Karakashev, Sergey, Zhang, Rugang
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7469455/
https://ncbi.nlm.nih.gov/pubmed/32944622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2020.1760675
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!